Research and Markets (http://www.researchandmarkets.com/research/2c6t6j/brain_hemorrhage_g) has announced the addition of GlobalData's new report "Brain Hemorrhage Global Clinical Trials Review, H1, 2012" to their offering.
GlobalData's clinical trial report, Brain Hemorrhage Global Clinical Trials Review, H1, 2012" provides data on the Brain Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts
Key Topics Covered:
- Brain Hemorrhage
- Report Guidance
- Clinical Trials by Region
- Clinical Trials by Country
- Top Five Countries Contributing to Clinical Trials in Asia-Pacific
- Top Five Countries Contributing to Clinical Trials in Europe
- Top Countries Contributing to Clinical Trials in North America
- Top Countries Contributing to Clinical Trials in Middle East and Africa
- Top Countries Contributing to Clinical Trials in Central and South America
- Clinical Trials by BRIC Nations
- Clinical Trials by G7 Nations
- Clinical Trials in G7 Nations by Trial Status
- Clinical Trials by E7 Nations
- Clinical Trials in E7 Nations by Trial Status
- Clinical Trials by Phase
- In Progress Trials by Phase
- Clinical Trials by Trial Status
- Unaccomplished Trials of Brain Hemorrhage
- Subjects Recruited Over a Period of Time
- Prominent Sponsors
- Top Companies Participating in Brain Hemorrhage Therapeutics Clinical Trials
- Prominent Drug Comparison
- Clinical Trial Profiles
- Clinical Trial Overview of Top Companies
- Five Key Clinical Profiles
- Eli Lilly and Company
- Johnson & Johnson
- Merck & Co.Inc
- Bristol-Myers Squibb Company
- Abbott Laboratories
- Hoffmann-La Roche Ltd.
- Celgene Corporation
- Daiichi Sankyo Company Ltd.
- Bayer AG
- Eisai Inc.
- GE Healthcare
- Biogen Idec Inc.
- Copharos Inc.
- Wyeth Pharmaceuticals Inc.
- National Cancer Center
- The University of Texas
- M.D. Andersons
- Vanderbilt Medical Center
- Memorial Sloan Kettering Cancer Center
- Cancer Research UK
- North Central Cancer Group
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University
- Fred Hutchinson Cancer Research Center
- European Organization for Research and Treatment of Cancer
- Dana-Farber Cancer Institute
- The Cancer and Leukemia Group B
- Columbia University
- UCLA's Jonsson Comprehensive Cancer Center
- Case Comprehensive Cancer Center
- Mayo Clinic
- Duke University
- Ohio State University
- National Cancer Center
- University of Pennsylvania.
For more information visit http://www.researchandmarkets.com/research/2c6t6j/brain_hemorrhage_g
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here